227 related articles for article (PubMed ID: 15257072)
41. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
42. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients.
Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P
Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.
Le Guellec C; Büchler M; Giraudeau B; Le Meur Y; Gakoué JE; Lebranchu Y; Marquet P; Paintaud G
Eur J Clin Pharmacol; 2002 Jan; 57(11):805-11. PubMed ID: 11868803
[TBL] [Abstract][Full Text] [Related]
44. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
[TBL] [Abstract][Full Text] [Related]
45. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
Troncoso P; Ortiz AM; Jara A; Vilches S
Transplant Proc; 2009; 41(1):127-30. PubMed ID: 19249495
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
47. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
[TBL] [Abstract][Full Text] [Related]
48. Rationale for monitoring cyclosporine concentration at 2 hours after administration in infants posttransplantation.
Furlan V; Lykavieris P; Maubert MA; Habes D; Debray D
Transplant Proc; 2009 Oct; 41(8):3333-4. PubMed ID: 19857744
[TBL] [Abstract][Full Text] [Related]
49. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
50. Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children.
Filler G; Feber J; Lepage N; Weiler G; Mai I
Pediatr Transplant; 2002 Oct; 6(5):411-8. PubMed ID: 12390429
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil.
Julasareekul W; Eiam-Ong S; Bejraputra O; Seublinvong T
J Med Assoc Thai; 2003 Aug; 86(8):766-71. PubMed ID: 12948276
[TBL] [Abstract][Full Text] [Related]
52. A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients.
Cremers SC; Scholten EM; Schoemaker RC; Lentjes EG; Vermeij P; Paul LC; den Hartigh J; de Fijter JW
Nephrol Dial Transplant; 2003 Jun; 18(6):1201-8. PubMed ID: 12748356
[TBL] [Abstract][Full Text] [Related]
53. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
54. Cyclosporin C2hour monitoring after renal transplantation.
Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Glander P; Böhler T; Neumayer HH; Budde K
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):477-81. PubMed ID: 14703954
[TBL] [Abstract][Full Text] [Related]
55. Cyclosporine A monitoring--how to account for twice and three times daily dosing.
Fanta S; Backman JT; Seikku P; Holmberg C; Hoppu K
Pediatr Nephrol; 2005 May; 20(5):591-6. PubMed ID: 15772834
[TBL] [Abstract][Full Text] [Related]
56. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables.
Ghio L; Ferraresso M; Zacchello G; Murer L; Ginevri F; Belingheri M; Peruzzi L; Zanon F; Perfumo F; Berardinelli L; Tirelli S; Dello Strologo L; Fontana I; Valente U; Cardillo M; Edefonti A
Clin Transplant; 2009; 23(2):264-70. PubMed ID: 19191807
[TBL] [Abstract][Full Text] [Related]
58. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
de Winter BC; van Gelder T; Mathot RA; Glander P; Tedesco-Silva H; Hilbrands L; Budde K; van Hest RM
Ther Drug Monit; 2009 Oct; 31(5):585-91. PubMed ID: 19704401
[TBL] [Abstract][Full Text] [Related]
59. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.
Balshaw R; Machnicki G; Carreño CA; Toselli L; Otero A; Keown PA
Transplant Proc; 2005 Mar; 37(2):871-4. PubMed ID: 15848560
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
